β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition CA Jurgens, MN Toukatly, CL Fligner, J Udayasankar, SL Subramanian, ... The American journal of pathology 178 (6), 2632-2640, 2011 | 393 | 2011 |
Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis S Zraika, RL Hull, J Udayasankar, K Aston-Mourney, SL Subramanian, ... Diabetologia 52, 626-635, 2009 | 255 | 2009 |
Differential effect of inbred mouse strain (C57BL/6, DBA/2, 129T2) on insulin secretory function in response to a high fat diet S Andrikopoulos, CM Massa, K Aston-Mourney, A Funkat, BC Fam, ... Journal of Endocrinology 187 (1), 45-53, 2005 | 161 | 2005 |
Too much of a good thing: why it is bad to stimulate the beta cell to secrete insulin K Aston-Mourney, J Proietto, G Morahan, S Andrikopoulos Diabetologia 51, 540-545, 2008 | 113 | 2008 |
Increased nicotinamide nucleotide transhydrogenase levels predispose to insulin hypersecretion in a mouse strain susceptible to diabetes K Aston-Mourney, N Wong, M Kebede, S Zraika, L Balmer, JM McMahon, ... Diabetologia 50, 2476-2485, 2007 | 95 | 2007 |
cJUN N-terminal kinase (JNK) activation mediates islet amyloid-induced beta cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets SL Subramanian, RL Hull, S Zraika, K Aston-Mourney, J Udayasankar, ... Diabetologia 55, 166-174, 2012 | 88 | 2012 |
Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets J Udayasankar, K Kodama, RL Hull, S Zraika, K Aston-Mourney, ... Diabetologia 52, 145-153, 2009 | 83 | 2009 |
Amyloid formation in human IAPP transgenic mouse islets and pancreas, and human pancreas, is not associated with endoplasmic reticulum stress RL Hull, S Zraika, J Udayasankar, K Aston-Mourney, SL Subramanian, ... Diabetologia 52, 1102-1111, 2009 | 82 | 2009 |
Fructose-1, 6-bisphosphatase overexpression in pancreatic β-cells results in reduced insulin secretion: a new mechanism for fat-induced impairment of β-cell function M Kebede, J Favaloro, JE Gunton, DR Laybutt, M Shaw, N Wong, BC Fam, ... Diabetes 57 (7), 1887-1895, 2008 | 82 | 2008 |
Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets K Aston-Mourney, RL Hull, S Zraika, J Udayasankar, SL Subramanian, ... Diabetologia 54, 1756-1765, 2011 | 69 | 2011 |
The influence of genetic background on the induction of oxidative stress and impaired insulin secretion in mouse islets S Zraika, K Aston-Mourney, DR Laybutt, M Kebede, ME Dunlop, J Proietto, ... Diabetologia 49, 1254-1263, 2006 | 67 | 2006 |
Clinical features, complications and treatment of rarer forms of maturity-onset diabetes of the young (MODY)-A review R Aarthy, K Aston-Mourney, A Mikocka-Walus, V Radha, A Amutha, ... Journal of Diabetes and its Complications 35 (1), 107640, 2021 | 56 | 2021 |
One year of sitagliptin treatment protects against islet amyloid-associated β-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice K Aston-Mourney, SL Subramanian, S Zraika, T Samarasekera, DT Meier, ... American Journal of Physiology-Endocrinology and Metabolism 305 (4), E475-E484, 2013 | 54 | 2013 |
High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction S Kooptiwut, M Kebede, S Zraika, S Visinoni, K Aston-Mourney, ... Journal of molecular endocrinology 35 (1), 39-48, 2005 | 51 | 2005 |
Neprilysin impedes islet amyloid formation by inhibition of fibril formation rather than peptide degradation S Zraika, K Aston-Mourney, P Marek, RL Hull, PS Green, J Udayasankar, ... Journal of Biological Chemistry 285 (24), 18177-18183, 2010 | 47 | 2010 |
Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide K Aston-Mourney, S Zraika, J Udayasankar, SL Subramanian, PS Green, ... Journal of Biological Chemistry 288 (5), 3553-3559, 2013 | 41 | 2013 |
Adipocytokines as features of the metabolic syndrome determined using confirmatory factor analysis MM Smits, P Woudstra, KM Utzschneider, J Tong, F Gerchman, ... Annals of epidemiology 23 (7), 415-421, 2013 | 37 | 2013 |
Advanced glycation end-products and their effects on gut health K Phuong-Nguyen, BA McNeill, K Aston-Mourney, LR Rivera Nutrients 15 (2), 405, 2023 | 26 | 2023 |
Scriptaid enhances skeletal muscle insulin action and cardiac function in obese mice V Gaur, T Connor, K Venardos, DC Henstridge, SD Martin, C Swinton, ... Diabetes, Obesity and Metabolism 19 (7), 936-943, 2017 | 23 | 2017 |
Quality of Life and Diabetes in India: A Scoping Review R Aarthy, A Mikocka-Walus, R Pradeepa, RM Anjana, V Mohan, ... Indian Journal of Endocrinology and Metabolism 25 (5), 365-380, 2021 | 19 | 2021 |